Steven Cohen Portfolio Holdings

Point72 Asset Management, L.P.

  • $36 Billion
  • Q2 2024

Point72 Asset Management, L.P., under direction of Steven Cohen has filed its 13F form on September 16, 2024 for Q2 2024 where it was disclosed a total value porftolio of $36 Billion distributed in 1790 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Amazon Com Inc with a value of $611M, Apple Inc. with a value of $331M, Dell Technologies Inc. with a value of $329M, Kroger CO with a value of $269M, and Nvidia Corp with a value of $261M.

Examining the 13F form we can see an increase of $499K in the current position value, from $36B to 36B.

Point72 Asset Management, L.P. is based out at Stamford, CT

Below you can find more details about Steven Cohen portfolio as well as his latest detailed transactions.

Portfolio value $36 Billion
Technology: $6.7 Billion
Healthcare: $5.19 Billion
ETFs: $4.58 Billion
Consumer Cyclical: $4.4 Billion
Industrials: $3.71 Billion
Energy: $2.49 Billion
Consumer Defensive: $2.37 Billion
Financial Services: $2.16 Billion
Other: $4.44 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.78B
$152,000 0.0% of portfolio
66,500
Q2 2024 New
$494M
$214,000 0.0% of portfolio
20,800
Q2 2024 Added 22.35%
$226M
$130,000 0.0% of portfolio
19,133
Q2 2024 New
$13.9B
$1.48 Million 0.0% of portfolio
52,152
Q2 2024 New
Cooper Cos Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 480.09%
$2.71B
$600,000 0.0% of portfolio
24,922
Q2 2024 Added 18.68%
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 69.14%
Core Scientific Inc New
-
$0 0.0% of portfolio
-
Q2 2024 New
Core Scientific Inc New
-
$0 0.0% of portfolio
-
Q2 2024 New
$728M
$237,000 0.0% of portfolio
13,000
Q2 2024 Added 5.69%
$1.01B
$441,000 0.0% of portfolio
61,600
Q2 2024 New
$508M
$90,000 0.0% of portfolio
4,800
Q2 2024 New
$592M
$166,000 0.0% of portfolio
14,084
Q2 2024 Reduced 56.93%
$23.9B
$0 0.0% of portfolio
-
Q2 2024 Reduced 73.25%
$2.03B
$124,000 0.0% of portfolio
3,300
Q2 2024 Added 312.5%
$1.49B
$177,000 0.0% of portfolio
4,300
Q2 2024 Reduced 29.51%
$2.94B
$300,000 0.0% of portfolio
28,910
Q2 2024 New
Cyclacel Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Cytokinetics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 136.67%
Dave Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Dbv Technologies S A
-
$0 0.0% of portfolio
-
Q2 2024 New
$420M
$1.16 Million 0.0% of portfolio
213,109
Q2 2024 Reduced 73.84%
$1.69B
$455,000 0.0% of portfolio
39,400
Q2 2024 New
$70.7B
$874,000 0.0% of portfolio
6,933
Q2 2024 Added 333.31%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 50.53%
$1.03B
$209,000 0.0% of portfolio
9,157
Q2 2024 New
Digitalbridge Group Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 125.37%
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
$830M
$61,000 0.0% of portfolio
20,212
Q1 2024 Reduced 82.35%
$1.36B
$852,000 0.0% of portfolio
105,320
Q2 2024 New
Docebo Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
$367M
$361,000 0.0% of portfolio
116,844
Q2 2024 Reduced 69.04%
$1.53B
$295,000 0.0% of portfolio
24,167
Q2 2024 Added 4.62%
$49.1B
$1.06 Million 0.0% of portfolio
21,591
Q2 2024 Reduced 98.92%
$1.68B
$283,000 0.0% of portfolio
4,751
Q2 2024 New
$1.18B
$1.55 Million 0.0% of portfolio
36,953
Q2 2024 Added 49.0%
$525M
$159,000 0.0% of portfolio
6,836
Q2 2024 Added 113.63%
$837M
$35,000 0.0% of portfolio
1,864
Q2 2024 New
$10.1B
$830,000 0.0% of portfolio
4,700
Q2 2024 Added 123.81%
$824M
$141,000 0.0% of portfolio
11,325
Q2 2024 Reduced 97.01%
$64.1B
$914,000 0.0% of portfolio
8,301
Q2 2024 Reduced 95.37%
$1.3B
$37,000 0.0% of portfolio
870
Q2 2024 Reduced 13.0%
$5.27B
$699,000 0.0% of portfolio
22,800
Q2 2024 Added 267.74%
$1.09B
$215,000 0.0% of portfolio
5,165
Q2 2024 Reduced 20.54%
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 75.96%
$53.4B
$1.25 Million 0.0% of portfolio
40,600
Q2 2024 New
$523M
$32,000 0.0% of portfolio
1,500
Q2 2024 New
$1.96B
$384,000 0.0% of portfolio
9,391
Q2 2024 Added 61.91%
$195M
$673,000 0.0% of portfolio
530,259
Q2 2024 Reduced 77.96%
Steven Cohen

Steven Cohen

Steven Cohen is the founder and CEO of Point72 Asset Management, a successful investment firm that uses technology and data-driven approaches to investing. Cohen is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Steven Cohen's portfolio

Summary

  • Portfolio
  • No. of Stocks 1,790
  • Current Value $36 Billion
  • Prior Value $36 Billion
  • Filing
  • Period Q2 2024
  • Filing Date September 16, 2024
  • Form Type 13F-HR/A
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email